Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults
Universitat Pompeu Fabra · Instituto de Salud Carlos III · +25 more institutions
Abstract
Over one million European children undergo computed tomography (CT) scans annually. Although moderate- to high-dose ionizing radiation exposure is an established risk factor for hematological malignancies, risks at CT examination dose levels remain uncertain. Here we followed up a multinational cohort (EPI-CT) of 948,174 individuals who underwent CT examinations before age 22 years in nine European countries. Radiation doses to the active bone marrow were estimated on the basis of body part scanned, patient characteristics, time period and inferred CT technical parameters. We found an association between cumulative dose and risk of all hematological malignancies, with an excess relative risk of 1.96 (95%…
Citation impact
- FWCI
- 65.39
- Percentile
- 100%
- References
- 37
Authors
33- MBMagda Bosch de Basea GómezCorresponding
Universitat Pompeu Fabra, Instituto de Salud Carlos III, Barcelona Institute for Global Health, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
- ITIsabelle Thierry-Chef
Universitat Pompeu Fabra, Instituto de Salud Carlos III, Barcelona Institute for Global Health, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Centre international de recherche sur le cancer
- RHRichard Harbron
Universitat Pompeu Fabra, Instituto de Salud Carlos III, Barcelona Institute for Global Health, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Newcastle University
- MHMichael Hauptmann
Medizinische Hochschule Brandenburg Theodor Fontane
- GBGraham Byrnes
Centre international de recherche sur le cancer
Topics & keywords
- Medicine
- Radiation exposure
- Pediatrics
- Young adult
- Oncology
- Internal medicine
- Nuclear medicine
- Good health and well-being
Funding
- UDU.S. Department of Energy
- KBKræftens Bekæmpelse
- VUVanderbilt University Medical Center
- CDCentres de Recerca de CatalunyaAwards: CEX2018-000806-S, 501100011033, MCIN/AEI/10.13039/501100011033
- NINational Institute for Health Research Health Protection Research Unit
- UGUniversitätsmedizin Göttingen
- CRCancer Research UK
- NINational Institute for Health and Care Research
- NUNewcastle University
- PHPublic Health England
- BFBundesministerium für Bildung und ForschungAward: 02NUK016A
- GDGeneralitat de CatalunyaAwards: 10.13039/501100011033, 501100011033, MCIN/AEI/10.13039/501100011033, CEX2018-000806-S, PI16/00120, 2017 SGR
- MOMinistry of Health, Labour and WelfareAward: 2012-02-21-01
- KIKorea Institute of Construction Technology
- UMUniversitair Medisch Centrum Utrecht
- LCLigue Contre le CancerAwards: PRE09/MOB, PRE09
- MUMaastricht Universitair Medisch Centrum
- IDInstitut de Radioprotection et de SÛreté Nucléaire
- KKKWF Kankerbestrijding
- SASt. Antonius Ziekenhuis
- LULeids Universitair Medisch Centrum
- CHCentre Hospitalier Régional Universitaire de Montpellier
- NFNorges ForskningsrådAward: MCIN/AEI/10.13039/501100011033
- GFGoethe-Universität Frankfurt am Main
- CDConsejo de Seguridad NuclearAward: MCIN/AEI/10.13039/501100011033
- RURadboud Universitair Medisch Centrum
- INInstitut National Du Cancer
- UJUniversitätsklinikum Jena
- HNHelse Nord-Trøndelag
- APAssistance publique-Hôpitaux de Paris
- SOSt. Olavs Hospital Universitetssykehuset i Trondheim
- VRVlaamse regering
- STSykehuset Telemark
- UEUniversitätsklinikum Erlangen
- UMUniversitätsmedizin Mannheim
- UTUniversitätsklinikum Tübingen
- ADAgència de Gestió d'Ajuts Universitaris i de RecercaAwards: 10.13039/501100011033, 13039/501100011033, MCIN/AEI/10.13039/501100011033, CEX2018-000806-S, 2017 SGR
- IDInstituto de Salud Carlos IIIAwards: PI16/, PI16/00120, MCIN/AEI/10.13039/501100011033, /10.13039/501100011033, CEX2018-000806-S, AEI/10.13039/501100011033
- EREuropean Regional Development FundAwards: MCIN/AEI/10, MCIN/AEI/10.13039/501100011033, 10.13039/501100011033, 13039/501100011033, AEI/10.13039/501100011033, 501100011033
- AEAgencia Estatal de InvestigaciónAwards: AEI/10.13039/501100011033, 501100011033, by MCIN/AEI/10.13039/501100011033, 10.13039/501100011033, MCIN/AEI/10.13039/501100011033, 13039, 10.13039, AEI/10, CEX2018-000806-S, 13039/501100011033, AEI/10.
- UDUniversitätsmedizin der Johannes Gutenberg-Universität Mainz
- NCNational Cancer Institute
- FNFP7 Nuclear Fission, Safety and Radiation ProtectionAward: 269912